MyFinsight
Home
Blog
About
Contact
Download
Download image
Spinraza Royalties
$55,896K
Wainus Royalties
$13,320K
Other Royalties
$6,478K
Net loss
-$128,606K
(8.45%↑ Y/Y)
Royalty
$75,694K
Product
$31,792K
Other Commercial
$8,112K
Collaborative Agreement
Revenue
$31,436K
(-29.96%↓ Y/Y)
Wainua Joint
Development Revenue
$9,685K
(-26.63%↓ Y/Y)
Loss before income
tax benefit...
-$128,393K
(10.90%↑ Y/Y)
Income tax benefit
(expense)
$213K
(105.88%↑ Y/Y)
Gain (loss) on
investments, net
$29,908K
(3302.50%↑ Y/Y)
Investment income
$23,682K
(-9.71%↓ Y/Y)
Commercial
$115,598K
Research And Development
Revenue
$41,121K
Other income, net
$363K
(155.63%↑ Y/Y)
Loss from operations
-$160,182K
(-7.75%↓ Y/Y)
Revenue
$156,719K
(17.12%↑ Y/Y)
Interest expense related
to sale of future...
$17,952K
(-3.13%↓ Y/Y)
Interest expense
$4,212K
(1.23%↑ Y/Y)
Total operating
expenses
$316,901K
(12.19%↑ Y/Y)
Research, development and
patent
$217,754K
(-0.91%↓ Y/Y)
Selling, general and
administrative
$96,809K
(57.06%↑ Y/Y)
Cost of sales
$2,338K
(118.30%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
IONIS PHARMACEUTICALS INC (IONS)
IONIS PHARMACEUTICALS INC (IONS)